Sunesis Pharmaceuticals Competitors and Similar CompaniesClear all

Sunesis Pharmaceuticals's competitors and similar companies include PLIVA, Biocon and Shanghai Junshi Biosciences.

	Sunesis Pharmaceuticals Sunesis Pharmaceuticals is focused on the R&D of oncology therapeutics for the treatment of solid and hematologic cancers.	PLIVA PLIVA HRVATSKA is a pharmaceutical company focused on the development of generic and niche products.	Biocon Biocon is a global biopharmaceutical company.	Shanghai Junshi Biosciences Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases.
Founding Date	Founding Date 1987	Founding Date 1921	Founding Date 1978	Founding Date 2012
Type	Type Subsidiary	Type Subsidiary	Type Public	Type Public
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations South San Francisco, US HQ	Locations Zagreb, HR HQ Sarajevo, BA Skopje, MK Belgrade, RS	Locations Bengaluru, IN HQ Bengaluru, IN Hyderabad, IN Visakhapatnam, IN Dublin, IE Kuala Lumpur, MY Puchong, MY see more	Locations Shanghai, CN HQ
Employees	Employees 422% decrease	Employees 1,647	Employees 16,315	Employees 2,5681% increase
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ₹142b (FY, 2024)	Revenue (est.) ¥1.5b (FY, 2023)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods ₹50.9b (FY, 2024)	Cost of goods ¥541m (FY, 2023)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit ₹102b (FY, 2024)	Gross profit ¥941.9m (FY, 2023)
Net income	Net income ($114.8m) (FY, 2021)	Net income N/A	Net income ₹13b (FY, 2024)	Net income (¥2.5b) (FY, 2023)